News

Filter

Current filters:

BayerDiabetes

201 to 210 of 97531 results

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

08-01-2015

Swiss oncology specialist Helsinn and Danish anemia drugmaker Pharmacosmos have entered into an agreement…

HelsinnHematologyLicensingMarkets & MarketingMonoferPharmaceuticalPharmacosmos

Increased R&D outsourcing by global pharma and biopharma driving CRO business

Increased R&D outsourcing by global pharma and biopharma driving CRO business

08-01-2015

Increased outsourcing of R&D activities is one of the main drivers of growth in the contract research…

CovanceMarkets & MarketingParexelPharmaceuticalProductionQuintiles

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

08-01-2015

Swiss drug major Novartis has signed collaboration and licensing agreements with Intellia Therapeutics…

GeneticsLicensingNovartisPharmaceuticalSwitzerland

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

07-01-2015

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for…

CanadaCipher PharmaceuticalsDermatologicalsFerrerLicensingOzenoxacinPharmaceutical

Indian government plans to establish dynamic and balanced IPR policy

Indian government plans to establish dynamic and balanced IPR policy

07-01-2015

Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on January…

IndiaPatentsPharmaceuticalPoliticsUSA

Aveo Oncology appoints Michael Bailey as president

Aveo Oncology appoints Michael Bailey as president

07-01-2015

Aveo Oncology has appointed Michael Bailey as president, chief executive and director.

AVEO OncologyBoardroomOncologyPharmaceuticalUSA

FDA grants Soligenix Fast Track status for SGX301

FDA grants Soligenix Fast Track status for SGX301

07-01-2015

Late-stage biopharma company Soligenix has said that its SGX301 (synthetic hypericin) development program…

OncologyPharmaceuticalRegulationSGX301SoligenixUSA

201 to 210 of 97531 results

Back to top